1-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperidin-4-ol, 97%, 250mg

2-(2,5-Dihydrofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

4-(5-Piperidin-4-yl-1,2,4-oxadiazol-3-yl)pyridine, 95.0%, 5g

2,6-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 5g

4-Amino-6-chloropyrimidin-5-ol, 95.0%, 10g

(S)-2-((S)-2-Amino-3-(1H-indol-3-yl)propanamido)-4-(trimethylsilyl)butanoic acid hydrochloride, 97%, 5mg

Objektträgerboxen, Anzahl der benötigten Plätze, 100, weiß 1 Stk

1-Ethylimidazolidin-2-one, 95+%, 100mg

BSA [=N,O-Bis(trimethylsilyl)acetamide] [for Gas Chromatography]>80.0%(GC)5mL

(R)-7-chloro-6-methoxy-4-((1-(pyridin-2-yl)ethyl)amino)quinoline-3-carboxamide, 95%, 100mg

3-(3,4-dichlorophenyl)prop-2-ynoic acid, 95.0%, 10g

3-(3-(Cyclopentylthio)-5-(((2-methyl-4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)oxy)methyl)-4H-1,2,4-triazol-4-yl)pyridine, 98%, 25mg

2-Decanoyloxazole, 97.0%, 1g